The acquisition marks a turning point for the company after months of financial uncertainty and data breach concerns.

Fierce 15 nominations are open! We're searching for the most innovative, resourceful and visionary biotechs leading the way through the industry's mercurial conditions.

FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT is a Hold.

CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a larger share of profit at 60%, this is worthwhile because Vertex has the solid commercial experience and infrastructure that could help make the product successful. Vertex also bears the biggest share of the costs.

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know from its history.

Walter Isaacson, ‘Elon Musk’ author, Perella Weinberg Partners advisory partner and Tulane professor, joins 'Squawk Box' to discuss breakthroughs in gene editing and biotech to cure diseases, impact of federal funding cuts,

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, June 1, 2025, at 6:00 p.m. CT (7:00 p.m. ET) during the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago,

Microsoft, Chevron, 10x Genomics, 23andMe, NetApp, NGM Biopharmaceuticals, Pliant Therapeutics and Downtown College Prep are among the employers that have decided to slash jobs in the Bay Area recently, a post by the state Employment Development Department shows.